RT Journal Article
SR Electronic
T1 Nipah virus outbreak in Kerala state, India amidst of COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.09.21267278
DO 10.1101/2021.12.09.21267278
A1 Yadav, Pragya D.
A1 Sahay, Rima R.
A1 Anukumar, B
A1 Mohandas, Sreelekshmy
A1 Radhakrishnan, Chandni
A1 Gokhale, Mangesh D
A1 Balasubramaniam, R
A1 Abraham, Priya
A1 Gupta, Nivedita
A1 Sugunan, AP
A1 Khobragade, Rajan
A1 George, Kalpana
A1 Shete, Anita
A1 Patil, Savita
A1 Thankappan, Ullas Padinjaremattathil
A1 Dighe, Hitesh
A1 Koshy, Jijo
A1 Vijay, Vivek
A1 Gayathri, R
A1 Kumar, P Jayesh
A1 Rahim, Asma
A1 Naveen, A.
A1 Nair, Sarala
A1 Rajendran, VR
A1 Jayasree, V
A1 Majumdar, Triparna
A1 Jain, Rajlaxmi
A1 Vishwanathan, Prasanth
A1 Patil, Deepak Y.
A1 Kumar, Abhinendra
A1 Nyayanit, Dimpal A.
A1 Sarkale, Prasad
A1 Waghmare, Ashwini
A1 Baradkar, Shrikant
A1 Gawande, Pranita
A1 Bodake, Poonam
A1 Kalele, Kaumudi
A1 Yemul, Jyoti
A1 Dhaigude, Sachin
A1 Holepannawar, Manjunath
A1 Gopale, Sanjay
A1 Chopade, Ganesh
A1 Narayan, Jitendra
A1 Mathapati, Basavaraj
A1 Kadam, Manoj
A1 Kumar, Abhimanyu
A1 Suryawanshi, Annasaheb
A1 Jose, Beena Philomina
A1 Sivadas, Saritha
A1 Akash, NP
A1 Vimisha, TV
A1 Keerthi, KV
YR 2021
UL http://medrxiv.org/content/early/2021/12/11/2021.12.09.21267278.abstract
AB Background We report here a Nipah virus (NiV) outbreak in Kozhikode district of Kerala state, India which had caused fatal encephalitis in an adolescent male and the outbreak response which led to the successful containment of the disease and the related investigations.Methods Quantitative real-time RT-PCR, ELISA based antibody detection and whole genome sequencing were performed to confirm the Nipah virus infection. Contacts of the index case were traced and isolated based on risk categorization. Bats from the areas near the epicenter of the outbreak were sampled for throat swabs, rectal swabs and blood samples for Nipah virus screening by real time RT-PCR and anti-Nipah virus bat IgG ELISA. Plaque reduction neutralization test was performed for the detection of neutralizing antibodies.Results Nipah viral RNA and anti-NiV IgG antibodies were detected in the serum of the index case. Rapid establishment of an onsite NiV diagnostic facility and contact tracing helped in quick containment of the outbreak. NiV sequences retrieved from the clinical specimen of the index case formed a sub-cluster with the earlier reported Nipah I genotype sequences from India with more than 95% similarity. Anti-NiV IgG positivity could be detected in 21% of Pteropus medius and 37.73% of Rousettus leschenaultia. Neutralizing antibodies against NiV could be detected in P.medius.Conclusions Stringent surveillance and awareness campaigns needs to be implemented in the area to reduce human-bat interactions and minimize spill over events which can lead to sporadic outbreaks of NiV.Competing Interest StatementThe authors have declared no competing interest.Funding StatementICMR supported the funding for this study under the mission-oriented project to the ICMR-National Institute of Virology, Pune. The funders had no role in study design, data collection or interpretation, or the decision to submit the work for publication. The findings and conclusions in this study are of the authors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by Institutional Ethics Committee, Institutional Biosafety Committee of Indian Council of Medical Research - National Institute of Virology, Pune and the Principal Chief Conservator of Forests, Government of Kerala.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors